Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Benvenue Medical, a developer of minimally invasive solutions for spine repair, has closed $15 million series B financing.
Subscribe to our email newsletter
The round included lead investor Three Arch Partners and returning investors Versant Ventures and De Novo Ventures.
Laurent Schaller, president and CEO of Benvenue Medical, said: “This financing will allow us to expand our product development programs, obtain additional regulatory approvals, and gain clinical experience with our minimally invasive spinal products.”